StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Grifols, S.A.
MCE:GRF.MC
Sector
Location
Market Cap
USD 7.63 B
Share Price
USD 12.43
Avg Daily Volume
2,454,292
Change (1 day)
-0.26%
Change (1 year)
33.23%
Change (YTD)
31.19%
Grifols, S.A. Total Assets for the year ending December 31, 2024: USD 22.16 B
Grifols, S.A. Total Assets is USD 22.16 B for the year ending December 31, 2024, a -6.34% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Grifols, S.A. Total Assets for the year ending December 31, 2023 was USD 23.67 B, a 2.71% change year over year.
-
Grifols, S.A. Total Assets for the year ending December 31, 2022 was USD 23.04 B, a 5.23% change year over year.
-
Grifols, S.A. Total Assets for the year ending December 31, 2021 was USD 21.89 B, a 17.34% change year over year.
-
Grifols, S.A. Total Assets for the year ending December 31, 2020 was USD 18.66 B, a 6.98% change year over year.
Competitors
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Regencell Bioscience Holdings Limited
USD 22.99
RGC
+12.63
121.91%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.18
2196.HK
+0.02
1.03%
Globus Medical, Inc.
USD 59.17
GMED
-1.40
-2.31%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.25
002653.SZ
+0.11
1.72%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.63
600566.SS
-0.01
-0.31%
Apeloa Pharmaceutical Co.,Ltd
USD 2.01
000739.SZ
+0.01
0.38%
Jubilant Pharmova Limited
USD 13.97
JUBLPHARMA.NS
-0.10
-0.68%
Shanghai Shyndec Pharmaceutical Co., Ltd.
USD 1.53
600420.SS
+0.02
1.51%
NovoCure Limited
USD 17.71
NVCR
-0.17
-0.95%
Tianjin Chase Sun Pharmaceutical Co.,Ltd
USD 0.55
300026.SZ
-0.00
-0.71%
Heilongjiang ZBD Pharmaceutical Co., Ltd.
USD 1.66
603567.SS
-0.07
-3.91%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Regencell Bioscience Holdings Limited
USD 22.99
RGC
+12.63
121.91%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.18
2196.HK
+0.02
1.03%
Globus Medical, Inc.
USD 59.17
GMED
-1.40
-2.31%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.25
002653.SZ
+0.11
1.72%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.63
600566.SS
-0.01
-0.31%
Apeloa Pharmaceutical Co.,Ltd
USD 2.01
000739.SZ
+0.01
0.38%
Jubilant Pharmova Limited
USD 13.97
JUBLPHARMA.NS
-0.10
-0.68%
Shanghai Shyndec Pharmaceutical Co., Ltd.
USD 1.53
600420.SS
+0.02
1.51%
NovoCure Limited
USD 17.71
NVCR
-0.17
-0.95%
Tianjin Chase Sun Pharmaceutical Co.,Ltd
USD 0.55
300026.SZ
-0.00
-0.71%
Heilongjiang ZBD Pharmaceutical Co., Ltd.
USD 1.66
603567.SS
-0.07
-3.91%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%